drug summary · 2 NDC codes
Tyvaso DPI
treprostinil
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | treprostinil |
|---|---|
| active ingredients | not reported |
| dosage form | KIT |
| route | not reported |
| strength | not reported |
| marketing status | NDA |
| DEA schedule | not reported |
| application number | NDA214324 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | United Therapeutics Corporation |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Prostacycline Vasodilator [EPC]; Prostaglandins I [CS]; Vasodilation [PE] |
NDC codes
2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 66302-610 | — |
| 66302061002 | — |
Other treprostinil products
16 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.
- OrenitramKIT · United Therapeutics Corporation
- Orenitram .125 mg/1TABLET, EXTENDED RELEASE · United Therapeutics Corporation
- Orenitram .25 mg/1TABLET, EXTENDED RELEASE · United Therapeutics Corporation
- Orenitram 1 mg/1TABLET, EXTENDED RELEASE · United Therapeutics Corporation
- Remodulin 100 mg/20mLINJECTION, SOLUTION · United Therapeutics Corporation
- Tyvaso DPI 16 ug/1INHALANT · United Therapeutics Corporation
- Orenitram 2.5 mg/1TABLET, EXTENDED RELEASE · United Therapeutics Corporation
- Remodulin 20 mg/20mLINJECTION, SOLUTION · United Therapeutics Corporation
- Remodulin 200 mg/20mLINJECTION, SOLUTION · United Therapeutics Corporation
- Tyvaso DPI 32 ug/1INHALANT · United Therapeutics Corporation
- Tyvaso DPI 48 ug/1INHALANT · United Therapeutics Corporation
- Orenitram 5 mg/1TABLET, EXTENDED RELEASE · United Therapeutics Corporation
4 more are listed in the drug product index.
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.